Weighing an Atlanta care offer
Ask which weight medicine, in which form.
A familiar ingredient name does not make every product with that name the same.
The body naturally produces a signal called GLP-1, which influences blood sugar and appetite. Weight medicines that imitate this signal are often called GLP-1 drugs. Ask for the exact product under discussion.
Begin with the ingredient and brand names
On September 26, 2026, the approved semaglutide brands included Ozempic and Wegovy; for tirzepatide, Mounjaro and Zepbound had FDA approval.
Semaglutide and tirzepatide are ingredient names, also called generic names. The names in brackets are brands. FDA means Food and Drug Administration.
The words “generic medicine” refer to a product: a reviewed copy of a brand medicine. A generic name is just the ingredient name.
As of September 26, 2026, no generic of semaglutide or tirzepatide had approval allowing sales in the United States.
Ask which form the health professional means and what condition it would treat.
A shortage story needs a date
Neither tirzepatide nor semaglutide injection appeared on the national FDA shortage list on September 26, 2026.
Compounding means making a drug to order.
A national shortage listing could permit otherwise restricted compounded copies, as of September 26, 2026. One local pharmacy’s empty stock did not suffice.
As of September 26, 2026, adding a vitamin did not automatically make a made-to-order copy of an available medicine legal.
Ask what specific patient need the prescriber is addressing.
New names need a separate check
As of September 26, 2026, federal law did not permit compounding with either retatrutide or cagrilintide, according to the FDA.
The agency had not found either safe and effective for any condition, as of September 26, 2026.
Ask about established options for your health concern. A name appearing in research is a reason to ask more, not a care plan.
Source notesOpen the notes behind this page
Follow the source that fits your question.
This link opens technical data about drug approvals. Ask a pharmacist to match your medicine’s exact name and form to the approval record.
This dated agency log explains how national shortage status affects compounding.
Look for “for research purposes” on the label or offer, as well as “not for human consumption”. Ask the health professional to explain any such wording.